Latest period
$26.62B
YoY change
+8.5%
5Y CAGR
+1.8%
Peak year (2025)
$28.73B
Latest annual
$28.73B
Total Equity history chart for CME Group (CME) from 2000 to 2025
Latest: $28.73B
Total Equity growth chart for CME Group (CME) from 2000 to 2025
Latest: +8.5%
Total Equity history table for CME Group (CME) from 2000 to 2025
| 2025 | $28.73B | +8.5% | +$2.24B | ||
| 2024 | $26.49B | -0.9% | −$251.00M | ||
| 2023 | $26.74B | -0.5% | −$140.80M | ||
| 2022 | $26.88B | -1.9% | −$520.60M | ||
| 2021 | $27.40B | +4.1% | +$1.08B | ||
| 2020 | $26.32B | +0.7% | +$191.00M | ||
| 2019 | $26.13B | +0.8% | +$210.40M | ||
| 2018 | $25.92B | +15.6% | +$3.51B | ||
| 2017 | $22.41B | +10.2% | +$2.07B | ||
| 2016 | $20.34B | -1.0% | −$211.10M | ||
| 2015 | $20.55B | -1.8% | −$371.70M | ||
| 2014 | $20.92B | -1.1% | −$231.30M | ||
| 2013 | $21.15B | -1.2% | −$264.30M | ||
| 2012 | $21.42B | -0.6% | −$132.90M | ||
| 2011 | $21.55B | +7.4% | +$1.49B | ||
| 2010 | $20.06B | +3.9% | +$759.10M | ||
| 2009 | $19.30B | +3.3% | +$612.40M | ||
| 2008 | $18.69B | +51.9% | +$6.38B | ||
| 2007 | $12.31B | +710.1% | +$10.79B | ||
| 2006 | $1.52B | +35.8% | +$400.41M | ||
| 2005 | $1.12B | +37.7% | +$306.09M | ||
| 2004 | $812.60M | +44.3% | +$249.60M | ||
| 2003 | $563.00M | +26.2% | +$116.86M | ||
| 2002 | $446.14M | +79.6% | +$197.77M | ||
| 2001 | $248.37M | +51.7% | +$84.69M | ||
| 2000 | $163.67M | — | — |
- 2025$28.73B+8.5%
- 2024$26.49B-0.9%
- 2023$26.74B-0.5%
- 2022$26.88B-1.9%
- 2021$27.40B+4.1%
- 2020$26.32B+0.7%
- 2019$26.13B+0.8%
- 2018$25.92B+15.6%
- 2017$22.41B+10.2%
- 2016$20.34B-1.0%
- 2015$20.55B-1.8%
- 2014$20.92B-1.1%
- 2013$21.15B-1.2%
- 2012$21.42B-0.6%
- 2011$21.55B+7.4%
- 2010$20.06B+3.9%
- 2009$19.30B+3.3%
- 2008$18.69B+51.9%
- 2007$12.31B+710.1%
- 2006$1.52B+35.8%
- 2005$1.12B+37.7%
- 2004$812.60M+44.3%
- 2003$563.00M+26.2%
- 2002$446.14M+79.6%
- 2001$248.37M+51.7%
- 2000$163.67M—
Total Equity values are taken from CME Group's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Equity at CME Group (CME)
According to CME Group's latest reported financial statements, the company's latest reported total equity is $26.62B. Net assets — also called stockholders' equity — equal total assets minus total liabilities. They represent the residual claim of shareholders on the company's assets and roughly track book value over time.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, CME Group (CME) total equity totalled $28.73B – grew 8.5% year-over-year.
CME Group total equity compound annual growth for the 2020–2025 (5 years) window is +1.8%, with mixed annual results across the window.
The record annual total equity stands at $28.73B, reached in 2025; the historical low of $163.67M was recorded in 2000.
CME Group Total Equity by Year
CME Group Total Equity 2025: $28.73B
In 2025, CME Group reported total equity of $28.73B, grew 8.5% from 2024. This figure represents the highest annual value in the available history.
CME Group Total Equity 2024: $26.49B
CME Group total equity in 2024 was $26.49B, edged down 0.9% below 2023.
CME Group Total Equity 2023: $26.74B
2023's total equity for CME Group came in at $26.74B, edged down 0.5% below 2022.
CME Group Total Equity 2022: $26.88B
CME Group posted total equity of $26.88B in 2022, edged down 1.9% below 2021.
CME Group Total Equity 2021: $27.40B
CME Group total equity in 2021 was $27.40B.
See more financial history for CME Group (CME).
Sector peers by Total Equity
Financial Services peers of CME Group (CME), ranked by their latest total equity
| $717.42B | |
| $362.44B | |
| $303.24B | |
| $181.12B | |
| $124.97B | |
| $111.63B | |
| $37.91B | |
| $7.74B |
- $717.42B
- $362.44B
- $303.24B
- $181.12B
- $124.97B
- $111.63B
- $37.91B
- $7.74B
Frequently asked questions
CME Group (CME) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation